Acute management of bleeding in patients on novel oral anticoagulants
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute management of bleeding in patients on novel oral anticoagulants
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 34, Issue 7, Pages 489-498
Publisher
Oxford University Press (OUP)
Online
2012-12-09
DOI
10.1093/eurheartj/ehs408
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
- (2012) Corey S. Miller et al. AMERICAN JOURNAL OF CARDIOLOGY
- Clinical Challenges in a Patient With Dabigatran-Induced Fatal Hemorrhage
- (2012) Ennie L. Cano et al. American Journal Geriatric Pharmacotherapy
- How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch
- (2012) S. Schulman et al. BLOOD
- Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
- (2012) Joachim Stangier et al. BLOOD COAGULATION & FIBRINOLYSIS
- Oral Anticoagulant Therapy
- (2012) Walter Ageno et al. CHEST
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
- (2012) M. N. LEVINE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation
- (2012) J. W. EIKELBOOM et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding Risk with Dabigatran in the Frail Elderly
- (2012) Paul Harper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Epidural Hematoma and Intraoperative Hemorrhage in a Spine Trauma Patient on Pradaxa (Dabigatran)
- (2012) Eeric Truumees et al. SPINE
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
- (2012) Robert G. Hart et al. STROKE
- Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
- (2012) Raphael Marlu et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: No increased risk of bleeding
- (2012) Andreas Kurth et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Prothrombin Complex Concentrate Versus Standard Therapies for INR Reversal in Trauma Patients Receiving Warfarin
- (2011) Scott A Chapman et al. ANNALS OF PHARMACOTHERAPY
- The Use of Dabigatran in Elderly Patients
- (2011) Matthieu Legrand ARCHIVES OF INTERNAL MEDICINE
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Laboratory assessment of new anticoagulants
- (2011) Meyer M. Samama et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement
- (2011) Ola E. Dahl et al. INTERNATIONAL ORTHOPAEDICS
- DABIGATRAN ANTICOAGULANT ACTIVITY IS NEUTRALIZED BY AN ANTIBODY SELECTIVE TO DABIGATRAN IN IN VITRO AND IN VIVO MODELS
- (2011) Joanne van Ryn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acutely Injured Patients on Dabigatran
- (2011) Bryan A. Cotton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
- (2011) Samuel Z. Goldhaber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
- (2011) Chiara Marchesi et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
- (2011) Genevieve Contant et al. THROMBOSIS AND HAEMOSTASIS
- Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement
- (2011) Geneviève Freyburger et al. THROMBOSIS RESEARCH
- Warfarin Dosing in Patients With Impaired Kidney Function
- (2010) Nita A. Limdi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
- (2010) A. HILLARP et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
- (2010) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
- (2010) Zhaoqing Wang et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
- (2010) Jean-Luc Martinoli et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
- (2010) Fariba Baghaei et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty
- (2010) Michael Rud Lassen et al. THROMBOSIS AND HAEMOSTASIS
- Use of Recombinant Activated Factor VII in Patients Without Hemophilia
- (2009) Cyrus C. Hsia et al. ANNALS OF SURGERY
- The new oral anticoagulants
- (2009) D. Garcia et al. BLOOD
- New Antithrombotic Drugs
- (2009) P L Gross et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents
- (2009) M. A. CROWTHER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
- (2008) Sam Schulman et al. CHEST
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
- (2008) Bengt I Eriksson et al. CLINICAL PHARMACOKINETICS
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Recombinant activated factor VII use in the emergency department
- (2008) P E Fishman et al. EMERGENCY MEDICINE JOURNAL
- Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry
- (2008) G. Rohde JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies
- (2008) P. C. WONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
- (2008) Stephan A. Mayer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
- (2008) Michael N. Diringer et al. STROKE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More